Search Results

There are 9505 results for: content related to: Dopamine agonist use and the risk of heart failure

  1. Levodopa does not change cerebral vasoreactivity in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 4, April 2013, Pages: 469–475, Alexandre Krainik, Audrey Maillet, Vanessa Fleury, Mehmet Sahin, Irène Troprès, Laurent Lamalle, Stephane Thobois, Valerie Fraix, Marjorie Villien, Jan Warnking, Pierre Pollak, Serge Pinto and Paul Krack

    Article first published online : 12 DEC 2012, DOI: 10.1002/mds.25267

  2. Risk of cancer in patients exposed to gabapentin in two electronic medical record systems

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 214–225, Michael C. Irizarry, David J. Webb, Nada Boudiaf, John Logie, Laurel A. Habel, Natalia Udaltsova and Gary D. Friedman

    Article first published online : 6 DEC 2011, DOI: 10.1002/pds.2266

  3. Stroke risk and NSAIDs: a systematic review of observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 12, December 2011, Pages: 1225–1236, Cristina Varas-Lorenzo, Nuria Riera-Guardia, Brian Calingaert, Jordi Castellsague, Antoine Pariente, Lorenza Scotti, Miriam Sturkenboom and Susana Perez-Gutthann

    Article first published online : 3 OCT 2011, DOI: 10.1002/pds.2227

  4. Major bleeding risk associated with warfarin and co-medications in the elderly population

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1057–1063, Agnes I. Vitry, Elizabeth E. Roughead, Emmae N. Ramsay, Adrian K. Preiss, Philip Ryan, Andrew L. Gilbert, Gillian E. Caughey, Sepehr Shakib, Adrian Esterman, Ying Zhang and Robyn A McDermott

    Article first published online : 17 AUG 2011, DOI: 10.1002/pds.2219

  5. Record linkage for pharmacoepidemiological studies in cancer patients

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 94–103, Myrthe P. P. van Herk-Sukel, Valery E. P. P. Lemmens, Lonneke V. van de Poll-Franse, Ron M. C. Herings and Jan Willem W. Coebergh

    Article first published online : 2 AUG 2011, DOI: 10.1002/pds.2205

  6. Use and costs of oral anticancer agents in the Netherlands in the period 2000–2008

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1036–1044, Lonneke Timmers, Jan Jacob Beckeringh, Myrthe P. P. van Herk-Sukel, Epie Boven and Jacqueline G. Hugtenburg

    Article first published online : 29 SEP 2011, DOI: 10.1002/pds.2225

  7. Comorbidities in an asthma population 8–29 years old: a study from the Norwegian Prescription Database

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1045–1052, Øystein Karlstad, Per Nafstad, Aage Tverdal, Svetlana Skurtveit and Kari Furu

    Article first published online : 23 SEP 2011, DOI: 10.1002/pds.2233

  8. Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 70–78, Jennifer L. Beebe-Dimmer, Karynsa Cetin, Vahakn Shahinian, Hal Morgenstern, Cecilia Yee, Kendra L. Schwartz and John Acquavella

    Article first published online : 24 NOV 2011, DOI: 10.1002/pds.2258

  9. Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 11, November 2011, Pages: 1168–1176, Susan E. Andrade, Tiffany A. Moore Simas, Denise Boudreau, Marsha A. Raebel, Sengwee Toh, Beth Syat, Inna Dashevsky and Richard Platt

    Article first published online : 22 AUG 2011, DOI: 10.1002/pds.2217

  10. Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 442–449, Tim A. Bruckner, Ashley Hodgson, Chris Brown Mahoney, Brent D. Fulton, Peter Levine and Richard M. Scheffler

    Article first published online : 24 OCT 2011, DOI: 10.1002/pds.2264

  11. Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 11, November 2011, Pages: 1130–1137, Rolf H. H. Groenwold, Frank de Vries, Anthonius de Boer, Wiebe R. Pestman, Frans H. Rutten, Arno W. Hoes and Olaf H. Klungel

    Article first published online : 23 SEP 2011, DOI: 10.1002/pds.2251

  12. Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 407–414, Catherine Corbell, Ishmael Katjitae, Assegid Mengistu, Francis Kalemeera, Evans Sagwa, David Mabirizi, Jennie Lates, Jude Nwokike, Sherrilyne Fuller and Andy Stergachis

    Article first published online : 18 OCT 2011, DOI: 10.1002/pds.2252

  13. Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 929–936, Kjell H. Halvorsen, Anne Gerd Granas, Anders Engeland and Sabine Ruths

    Article first published online : 13 SEP 2011, DOI: 10.1002/pds.2232

  14. Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 920–928, Emily S. Brouwer, Suzanne L. West, Marianne Kluckman, Dennis Wallace, Andrew L. Masica, Edward Ewen, Rustam Kudyakov, Dunlei Cheng, James Bowen and Neil S. Fleming

    Article first published online : 16 JAN 2012, DOI: 10.1002/pds.2262

  15. Safety aspects of antiepileptic drugs—focus on pharmacovigilance

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 11–20, Cecilie Johannessen Landmark and Svein I. Johannessen

    Article first published online : 8 NOV 2011, DOI: 10.1002/pds.2269

  16. Antipsychotic drugs and risk of pulmonary embolism

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 42–48, Benoit Allenet, Sophie Schmidlin, Céline Genty and Jean-Luc Bosson

    Article first published online : 4 NOV 2011, DOI: 10.1002/pds.2210

  17. Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1064–1072, Ellen S. Koster, Jan A. M. Raaijmakers, Susanne J. H. Vijverberg and Anke-Hilse Maitland-van der Zee

    Article first published online : 24 AUG 2011, DOI: 10.1002/pds.2228

  18. Spontaneous adverse event reports of Stevens–Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 289–296, Julie Papay, Nancy Yuen, Greg Powell, Maja Mockenhaupt and Thomas Bogenrieder

    Article first published online : 5 DEC 2011, DOI: 10.1002/pds.2276

  19. Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 79–86, Maria Bygdell, Gertrud Brunlöf, Susanna M. Wallerstedt and Jenny M. Kindblom

    Article first published online : 10 NOV 2011, DOI: 10.1002/pds.2265

  20. Data sources on drug safety evaluation: a review of recent published meta-analyses

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 21–33, Carlos Alves, Francisco Batel-Marques and Ana Filipa Macedo

    Article first published online : 25 OCT 2011, DOI: 10.1002/pds.2260